rss
Heart Asia 2009;2009:1-7 doi:10.1136/ha.2009.000976
  • Reviews in cardiovascular technology

Current endovascular therapy for lower extremity peripheral arterial disease: indications, outcomes and modalities

  1. B P Yan1,
  2. T J Kiernan2,
  3. Y-Y Lam1,
  4. C-M Yu1
  1. 1
    Division of Cardiology, Department of Medicine & Therapeutics, Prince of Wales Hospital and The Chinese University of Hong Kong, Hong Kong
  2. 2
    Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston Massachusetts, USA
  1. B P Yan, Division of Cardiology, Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; bryan.yan{at}cuhk.edu.hk
  • Accepted 13 August 2009

Abstract

Atherosclerosis of the lower extremities frequently leads to lifestyle-restricting claudication and can cause critical limb ischaemia (rest pain, non-healing ulcer, or gangrene). The prevalence of peripheral arterial disease (PAD) is rising in line with an ageing population. In the USA, PAD affects 8–10 million people (approximately 12% of the adult population). There is a strong association with concomitant coronary artery and cerebral vascular disease in these patients, which represents a significant cause of mortality and morbidity in patients with PAD. Disease affecting the lower extremity peripheral vessels is most aggressive in smokers and diabetics.

Footnotes

  • Competing interests: None declared.

  • Provenance and Peer review: Not commissioned; externally peer reviewed.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

All content in Heart Asia is free during 2009. Please register now to access the full text of all articles

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

"The publication of a premier cardiology journal, Heart Asia, by BMJ Publishing Group is a significant step forwards as this will become the preferred journal of choice for many of the original research work in the Asia Pacific region,"

Professor Vinay K Bahl, All India Institute of Medical Sciences, New Delhi

"The launch of Heart Asia will provide doctors in China a platform to publish their original research data and it is an important bridge that will allow the Chinese cardiologists to integrate with the international cardiology community,"

Professor Hu Dayi, Chief of the Heart Centre at Peking University’s People’s Hospital, Beijing

"Leading cardiology centres in the Asia Pacific region do some of the finest research in the world and the launch of Heart Asia is timely as it will allow top class research papers to be published in an Asia Pacific cardiology journal,"

Professor Ruey Jen Sung, Professor, Emeritus, Stanford University.

Latest from Heart

Latest from Heart

Latest from Heart